2010;90:1515 21. 545. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med. 1997; 336:153 62. 546. Yli-Mayry S, Huikuri HV, Korhonen UR, et al. efficacy and safety of anticoagulant therapy started pre-operatively in preventing coronary vein graft occlusion. Eur Heart J. 1992;13:1259 64. 547. Harker LA, Boissel JP, Pilgrim AJ, et al., CAPRIE Steering Committee and Investigators. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. Clopidogrel versus aspirin in patients at risk of ischaemic events. Drug Saf. 1999;21:325 35. 548. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circu- lation. 2002;106:3143 421. 549. Baigent C, Blackwell L, Emberson J, et al. efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 1670 81. 550. Pedersen TR, Faergeman O, Kastelein JJ, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocar-dial infarction: the IDEAL study: a randomized controlled trial [published correction appears in JAMA. 2005;294:3092]. JAMA. 2005;294: 2437 45. 551. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425 35. 552. MRC/BHF Heart Protection Study of cholesterol lowering with sim- vastatin in 20 536 high-risk individuals: a randomised placebo- controlled trial. Lancet. 2002;360:7 22. 553. Dotani MI, Elnicki DM, Jain AC, et al. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol. 2000;86:1128 30, A6. 554. Mannacio VA, Iorio D, De Amicis V, et al. 